Data / Form D filings / Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc.: Form D filings
Vicept Therapeutics, Inc., a pharmaceuticals company in Malvern, PA, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on June 29, 2010, reports $15.8 million sold of a $15.8 million offering to 12 investors.
Find out what Vicept Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 Lindenwood Drive, Suite 130, Malvern, PA, 19355
- Phone
- (484) 324-2930 x520
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2009
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1469750
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2010 | Amendment | $15,790,501 | $15,790,501 | $0 | 12 | Aug 4, 2009 | sec.gov |
| Aug 20, 2009 | New notice | $12,514,000 | $6,257,000 | $6,257,000 | 8 | Aug 4, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Powala | Executive Officer | |
| Albert Cha | Director | |
| Neal Walker | Executive Officer, Director | |
| Anand Mehra | Director | |
| Stephen Tullman | Director | |
| Thomas Beck | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Jun 28, 2010 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Vicept Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.